PMID- 28709971 OWN - NLM STAT- MEDLINE DCOM- 20180123 LR - 20180123 IS - 1873-6351 (Electronic) IS - 0278-6915 (Linking) VI - 107 IP - Pt A DP - 2017 Sep TI - Epigenetic mechanisms underlying the toxic effects associated with arsenic exposure and the development of diabetes. PG - 406-417 LID - S0278-6915(17)30393-9 [pii] LID - 10.1016/j.fct.2017.07.021 [doi] AB - BACKGROUND: Exposure to inorganic arsenic (iAs) is a major threat to the human health worldwide. The consumption of arsenic in drinking water and other food products is associated with the risk of development of type-2 diabetes mellitus (T2DM). The available experimental evidence indicates that epigenetic alterations may play an important role in the development of diseases that are linked with exposure to environmental toxicants. iAs seems to be associated with the epigenetic modifications such as alterations in DNA methylation, histone modifications, and micro RNA (miRNA) abundance. OBJECTIVE: This article reviewed epigenetic mechanisms underlying the toxic effects associated with arsenic exposure and the development of diabetes. METHOD: Electronic databases such as PubMed, Scopus and Google scholar were searched for published literature from 1980 to 2017. Searched MESH terms were "Arsenic", "Epigenetic mechanism", "DNA methylation", "Histone modifications" and "Diabetes". RESULTS: There are various factors involved in the pathogenesis of T2DM but it is assumed that arsenic consumption causes the epigenetic alterations both at the gene-specific level and generalized genome level. CONCLUSION: The research indicates that exposure from low to moderate concentrations of iAs is linked with the epigenetic effects. In addition, it is evident that, arsenic can change the components of the epigenome and hence induces diabetes through epigenetic mechanisms, such as alterations in glucose transport and/or metabolism and insulin expression/secretion. CI - Copyright (c) 2017 Elsevier Ltd. All rights reserved. FAU - Khan, Fazlullah AU - Khan F AD - International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran; Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. FAU - Momtaz, Saeideh AU - Momtaz S AD - Department of Pharmacology and Applied Medicine, Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. FAU - Niaz, Kamal AU - Niaz K AD - International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran; Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. FAU - Hassan, Fatima Ismail AU - Hassan FI AD - International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran; Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. FAU - Abdollahi, Mohammad AU - Abdollahi M AD - International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran; Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Mohammad.Abdollahi@UToronto.Ca. LA - eng PT - Journal Article PT - Review DEP - 20170711 PL - England TA - Food Chem Toxicol JT - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association JID - 8207483 RN - 0 (Drinking Water) RN - 0 (Insulin) RN - N712M78A8G (Arsenic) SB - IM MH - Animals MH - Arsenic/*toxicity MH - DNA Methylation MH - Diabetes Mellitus, Type 2/*etiology/genetics/metabolism MH - Drinking Water/analysis MH - Environmental Exposure/*adverse effects MH - Epigenesis, Genetic MH - Humans MH - Insulin/metabolism OTO - NOTNLM OT - Arsenic OT - DNA methylation OT - Diabetes OT - Epigenetic mechanisms OT - Histone modifications OT - miRNA EDAT- 2017/07/16 06:00 MHDA- 2018/01/24 06:00 CRDT- 2017/07/16 06:00 PHST- 2017/04/25 00:00 [received] PHST- 2017/07/07 00:00 [revised] PHST- 2017/07/08 00:00 [accepted] PHST- 2017/07/16 06:00 [pubmed] PHST- 2018/01/24 06:00 [medline] PHST- 2017/07/16 06:00 [entrez] AID - S0278-6915(17)30393-9 [pii] AID - 10.1016/j.fct.2017.07.021 [doi] PST - ppublish SO - Food Chem Toxicol. 2017 Sep;107(Pt A):406-417. doi: 10.1016/j.fct.2017.07.021. Epub 2017 Jul 11.